The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For ...
The Origin and differentiation characteristics of MSC. MSCs can be derived from various tissues and possess the capacity to differentiate into cartilage, bone, and fat cells. Additionally, MSCs have ...
Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...
Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi won the 2025 Nobel Prize in Medicine for discovering regulatory T cells, ...
Stem cell therapy reversed stroke damage in mice, regenerating neurons and restoring movement. The findings bring scientists ...
Emily Coiro is a stem cell nurse in New Jersey. After seeing her grandmother struggle with blood cancer, she decided to ...
Hope for adults and children with cancers Camilla Jandus' team is currently preparing a clinical trial of TCR-engineered CD4-based cell therapy. The trial will include different types of cancer ...
In a deal that could top $2 billion, China-based Innocare Pharma Ltd. licensed the worldwide development and commercialization rights to the BTK inhibitor orelabrutinib to Zenas Biopharma Inc. for ...
The prize-winning discovery explains how the immune system attacks hostile infections, but not the body's own cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback